Printer Friendly
The Free Library
14,598,645 articles and books
Member login
User name  
Password 
 
Join us Forgot password?

Zacks.com Announces That Dan Sullivan Highlights the Following Stocks: eBay, Avon Products, Gilead Sciences, PACCAR, and Tyson Foods.


CHICAGO -- Dan Sullivan is a nervous bull, as high oil and geopolitical ge·o·pol·i·tics  
n. (used with a sing. verb)
1. The study of the relationship among politics and geography, demography, and economics, especially with respect to the foreign policy of a nation.

2.
a.
 strife continue to cloud the positives in this marketplace. Stay ahead of the game with this expert's technical analysis and earnings news on five companies. Read about eBay (NASDAQ NASDAQ
 in full National Association of Securities Dealers Automated Quotations

U.S. market for over-the-counter securities. Established in 1971 by the National Association of Securities Dealers (NASD), NASDAQ is an automated quotation system that reports on
:EBAY), Avon Products (NYSE NYSE

See: New York Stock Exchange
:AVP AVP

arginine vasopressin.
), Gilead Sciences, Inc. (NASDAQ:GILD), PACCAR PACCAR Pacific Car and Foundry Company (former railroad car manufacturer now parent corp of Peterbilt & Kenworth Truck) , Inc. (NASDAQ:PCAR PCAR Pennsylvania Coalition Against Rape
PCAR Post Contract Award Review
), and Tyson Foods (NYSE:TSN TSN The Sporting News
TSN The Sports Network
TSN Targeting Social Need (NI)
TSN Tan Son Nhut (Vietnam)
TSN Time Since New
). Dan Sullivan is editor of The Chartist Chartist

Another name for technical analyst. This is a person who uses charts to identify patterns that can suggest future activity.

Notes:
Chartists use technical analysis for just about any type of financial security, especially stocks and commodities.
 newsletter. Click here for the full story exclusively on Zacks.com: http://at.zacks.com/?id=84

Here are the highlights from the Featured Expert column:

In summary, sentiment readings are becoming bullish, overbought/oversold readings are oversold Oversold

In technical analysis, it is a market in which the volume of selling that has occurred is greater than the fundamentals justify.

Notes:
It is the opposite of overbought.
, valuations are favorable and the economy, despite a slow down, continues to roll along. The four-year cycle and the presidential election cycle presidential election cycle

The tendency of the stock market to move in four-year cycles with rising markets occurring during the period before presidential elections.
 are still in the up phase. Money continues to pour into stock mutual funds like clockwork. Employee defined contribution plans (401k's) have barely altered their monthly allocation since 1996 with the majority going to stocks. Despite these positives, Dan Sullivan says he and his staff are nervous bulls. The world geopolitical situation and rising oil prices has certainly cast a pall over investors as they project further possible negative scenarios. A dose of good news would certainly be a welcome change.

Earnings Update

eBay (NASDAQ:EBAY) posted net revenues of $773.4 million for the second quarter 2004, up 52% compared to year ago numbers. Operating income rose 108% to $253.9 million. Consolidated net income for the second quarter was $190.4 million, or 28 cents per diluted share. Pro forma consolidated net income, excluding certain items, was $197.7 million, or 29 cents per diluted share. The results posted exceeded the company's guidance of $760 million for net revenues, or 24 cents per diluted share and 26 cents for pro forma earnings pro forma earnings

Income not necessarily calculated in accordance with generally accepted accounting principles. For example, a company might report pro forma earnings that exclude depreciation expense and nonrecurring expenses such as restructuring costs.
 per diluted share.

Avon Products (NYSE:AVP), the world's largest direct seller of cosmetics, posted a 35% jump in second-quarter profit and also raised its outlook for 2004. The company's net income was $232.3 million, or 49 cents per share Cents per share

The amount of a mutual fund's dividend or capital gains distributions that a shareholder will receive for each share owned.
, compared to $171.5 million, or 36 cents per share in the year-ago period. Avon's sales grew in every geographic region, rising 13% to $1.84 billion. Continued strong focus on international sales will keep this cosmetic behemoth in positive territory.

Gilead Sciences, Inc. (NASDAQ:GILD):Thanks to its flagship HIV HIV (Human Immunodeficiency Virus), either of two closely related retroviruses that invade T-helper lymphocytes and are responsible for AIDS. There are two types of HIV: HIV-1 and HIV-2. HIV-1 is responsible for the vast majority of AIDS in the United States.  drug Viread and its hepatitis B medicine, Gilead Sciences posted a quarterly net profit increase of 11%. The Foster City, California-based company posted net profit of $111.5 million, or 49 cents per share, in the second quarter, as compared with $100.4 million, or 46 cents per share the previous year. Total revenue rose 34% to $320 million. Revenue from product sales jumped 30% to $299.3 million.

PACCAR, Inc. (NASDAQ:PCAR) reported record profits for its second quarter 2004, with earnings of $236.5 billion, an increase of 91% over the same period last year. Second quarter net sales and financial services revenues were $2.79 billion, or 39% higher than the $2.01 billion reported for the same period last year. Management attributes the impressive numbers to the company's outstanding reputation as being one of the leading global companies that integrates leading-edge information technology, superior products and service quality with conservative fiscal management.

Tyson Foods (NYSE:TSN): Meat is still hot, though not quite as sizzling as Wall Street analysts expected, with Tyson Foods' third-quarter profits falling short of estimates. The company still posted profits that more than doubled those of the previous year's third quarter.

Read Dan Sullivan's complete commentary, and get earnings news on several other companies, by clicking: http://at.zacks.com/?id=85

About Zacks Featured Experts

To be a successful investor you need professional advice. Experts who know what they're talking about and can help you achieve your financial goals in good markets...and especially in bad ones will help you improve your portfolio. That is why Zacks Investment Research Zacks Investment Research

A firm that compiles earnings estimates and brokerage firm investment recommendations for thousands of publicly traded firms.
 has assembled the best investment experts in the business to offer their powerful advisory newsletters to you on all the major investment topics: Stocks, Mutual Funds, Bonds, Options, Futures etc.

Recommendations from Featured Experts Highlighted in FREE Investment Newsletter

The best way to tap into the powerful advice from these experts is through our free weekly e-mail newsletter, "Profit from the Pros". Each week we highlight several Featured Experts in this free e-mail newsletter. Get your free subscription to "Profit from the Pros" at: http://at.zacks.com/?id=86

About Zacks

Zacks.com is a property of Zacks Investment Research, Inc., which was formed in 1978 to compile, analyze, and distribute investment research to both institutional and individual investors. The guiding principle behind our work is the belief that investment experts, such as brokerage analysts and investment newsletter writers, have superior knowledge about how to invest successfully. Our goal is to unlock their profitable insights for our customers. And there is no better way to enjoy this investment success, than with a FREE subscription to "Profit from the Pros" weekly e-mail newsletter. For your free newsletter, visit http://at.zacks.com/?id=87

Zacks Investment Research is under common control with affiliated entities (including a broker-dealer and an investment adviser), which may engage in transactions involving the foregoing securities for the clients of such affiliates.

Disclaimer: Past performance does not guarantee future results. Investors should always research companies and securities before making any investments. Nothing herein should be construed as an offer or solicitation to buy or sell any security.
COPYRIGHT 2004 Business Wire
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2004, Gale Group. All rights reserved. Gale Group is a Thomson Corporation Company.

 Reader Opinion

Title:

Comment:



 

Article Details
Printer friendly Cite/link Email Feedback
Publication:Business Wire
Geographic Code:1USA
Date:Aug 17, 2004
Words:922
Previous Article:Vital Living Reports 253% Rise in Revenue for Second Quarter 2004.
Next Article:New $3.7 Million Security Contract Awarded to Secure Risks' Strategic Security Solutions Group.
Topics:



Related Articles
Zacks Issues Buy Recommendations On the Following 4 Stocks: CHIR, HGMCY, EBAY, and GILD.
Dan Sullivan Highlights the Following Stocks: Gilead Sciences, OmniVision Technologies, and H&R Block.
Dan Sullivan Recommends the Following Stocks: Avon Products, Gilead Sciences, Lexmark Int'l, and Yahoo.
Dan Sullivan Recommends the Following Stocks: Avon, Corinthian Colleges, Fidelity National Financial, Nextel, Paccar, and Scientific-Atlanta.
Zacks.com Announces that Dan Sullivan Highlights the Following Stocks: Apollo Group, Bear Stearns, Fidelity National Financial, and Paccar.
Zacks.com Announces that Dan Sullivan Highlights the Following Stocks: Zimmer Holdings and Gilead Sciences.
Zacks.com Announces That Dan Sullivan Highlights the Following Stocks: eBay, Gilead Sciences, JC Penney, TEVA Pharmaceutical, and YAHOO.
Zacks.com Announces That Nadine Wong Highlights: Genentech, Genzyme, Amgen, Celgene, and Gilead Sciences.
Zacks.com Announces That Nadine Wong Highlights: Genentech, Genzyme, and Gilead Sciences.
Zacks Buy List Highlights: Gilead Sciences, Inc., Amphenol Corporation, Mitsui & Co. Ltd. ADR, and Komag, Inc.

Terms of use | Copyright © 2009 Farlex, Inc. | Feedback | For webmasters | Submit articles